Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
Marinomed Biotech AG announces preliminary revenue for 2023
Marinomed Biotech AG with important progress for Carragelose in 2024
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
Lucia Ziegler, MSc
Head of Investor & Public Relations